InSilico Schedules 26 August Board Meeting to Approve H1-2026 Results and Consider Interim Dividend

Bulletin Express08-11 17:46

InSilico Medicine Cayman TopCo (abbreviated as “InSilico”) has set 26 August 2026 as the date for its upcoming board meeting. Directors will review and approve the Group’s interim financial results for the six months ended 30 June 2026 and discuss the declaration of an interim dividend, if any.

The session will also cover other routine corporate matters. The board currently comprises two executive directors—Chairman and CEO Dr. Aleksandrs Zavoronkovs and Dr. Feng Ren—one non-executive director, Dr. Chuen Yan Leung, and three independent non-executive directors: Dr. Jingsong Wang, Dr. Denitsa Milanova, and Mr. Roman Kyrychynskyi.

The announcement was released in Hong Kong on 11 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1100244765?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-11 17:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100244765","market":"hk","top_or_hot":-1,"title":"InSilico Schedules 26 August Board Meeting to Approve H1-2026 Results and Consider Interim Dividend","media":"Bulletin Express","content":"<p>InSilico Medicine Cayman TopCo (abbreviated as “InSilico”) has set 26 August 2026 as the date for its upcoming board meeting. Directors will review and approve the Group’s interim financial results for the six months ended 30 June 2026 and discuss the declaration of an interim dividend, if any.</p>\n<p>The session will also cover other routine corporate matters. The board currently comprises two executive directors—Chairman and CEO Dr. Aleksandrs Zavoronkovs and Dr. Feng Ren—one non-executive director, Dr. Chuen Yan Leung, and three independent non-executive directors: Dr. Jingsong Wang, Dr. Denitsa Milanova, and Mr. Roman Kyrychynskyi.</p>\n<p>The announcement was released in Hong Kong on 11 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>InSilico Schedules 26 August Board Meeting to Approve H1-2026 Results and Consider Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInSilico Schedules 26 August Board Meeting to Approve H1-2026 Results and Consider Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-11 17:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>InSilico Medicine Cayman TopCo (abbreviated as “InSilico”) has set 26 August 2026 as the date for its upcoming board meeting. Directors will review and approve the Group’s interim financial results for the six months ended 30 June 2026 and discuss the declaration of an interim dividend, if any.</p>\n<p>The session will also cover other routine corporate matters. The board currently comprises two executive directors—Chairman and CEO Dr. Aleksandrs Zavoronkovs and Dr. Feng Ren—one non-executive director, Dr. Chuen Yan Leung, and three independent non-executive directors: Dr. Jingsong Wang, Dr. Denitsa Milanova, and Mr. Roman Kyrychynskyi.</p>\n<p>The announcement was released in Hong Kong on 11 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1100244765","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100244765","pubTimestamp":1786441561,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"InSilico Medicine Cayman TopCo (abbreviated as “InSilico”) has set 26 August 2026 as the date for its upcoming board meeting. Directors will review and approve the Group’s interim financial results...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"InSilico 计划于 8 月 26 日召开董事会会议，批准 H1-2026 业绩并考虑中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"InSilico Medicine Cayman TopCo (abbreviated as “InSilico”) has set 26 August 2026 as the date for its upcoming board meeting. Directors will review and approve the Group’s interim financial results for the six months ended 30 June 2026 and discuss the declaration of an interim dividend, if any.\nThe session will also cover other routine corporate matters. The board currently comprises two executive directors—Chairman and CEO Dr. Aleksandrs Zavoronkovs and Dr. Feng Ren—one non-executive director, Dr. Chuen Yan Leung, and three independent non-executive directors: Dr. Jingsong Wang, Dr. Denitsa Milanova, and Mr. Roman Kyrychynskyi.\nThe announcement was released in Hong Kong on 11 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1100244765","isCrawlerRequest":true}